Found: 73
Select item for more details and to access through your institution.
Factors Associated With Rapid Progression to Endstage Kidney Disease in Lupus Nephritis.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Advanced Chronic Kidney Disease in Lupus Nephritis: Is Dialysis Inevitable?
- Published in:
- 2020
- By:
- Publication type:
- journal article
Atherosclerotic Vascular Events in Systemic Lupus Erythematosus: An Evolving Story.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Monophasic Disease Course in Systemic Lupus Erythematosus.
- Published in:
- 2018
- By:
- Publication type:
- journal article
More Consistent Antimalarial Intake in First 5 Years of Disease Is Associated with Better Prognosis in Patients with Systemic Lupus Erythematosus.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Hospitalizations in Patients with Systemic Lupus Erythematosus in an Academic Health Science Center.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Mycophenolate Mofetil in Nonrenal Manifestations of Systemic Lupus Erythematosus: An Observational Cohort Study.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Unfavorable Outcomes Associated With Glucocorticoid Use in Current Standard‐of‐Care Management of Systemic Lupus Erythematosus in Canada.
- Published in:
- ACR Open Rheumatology, 2024, v. 6, n. 9, p. 531, doi. 10.1002/acr2.11680
- By:
- Publication type:
- Article
Gradual Glucocorticosteroid Withdrawal Is Safe in Clinically Quiescent Systemic Lupus Erythematosus.
- Published in:
- ACR Open Rheumatology, 2021, v. 3, n. 8, p. 550, doi. 10.1002/acr2.11267
- By:
- Publication type:
- Article
Predictors of Good Long-Term Renal Outcomes in Lupus Nephritis: Results from a Single Lupus Cohort.
- Published in:
- BioMed Research International, 2017, v. 2017, p. 1, doi. 10.1155/2017/5312960
- By:
- Publication type:
- Article
Belantamab mafodotin, pomalidomide, and dexamethasone for triple class exposed/refractory relapsed multiple myeloma: a subgroup analysis of the ALGONQUIN trial.
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01135-2
- By:
- Publication type:
- Article
Real-world results of autologous stem cell transplantation in newly diagnosed multiple myeloma: a report from the Canadian Myeloma Research Group database.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00905-8
- By:
- Publication type:
- Article
Correction: Redefining attrition in multiple myeloma (MM): a Canadian Myeloma Research Group (CMRG) analysis.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00888-6
- By:
- Publication type:
- Article
Redefining attrition in multiple myeloma (MM): a Canadian Myeloma Research Group (CMRG) analysis.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00883-x
- By:
- Publication type:
- Article
Fabrication of Black Silicon Microneedle Arrays for High Drug Loading.
- Published in:
- Journal of Functional Biomaterials, 2023, v. 14, n. 5, p. 245, doi. 10.3390/jfb14050245
- By:
- Publication type:
- Article
Prevalence and associated factors of resting electrocardiogram abnormalities among systemic lupus erythematosus patients without cardiovascular disease.
- Published in:
- Arthritis Research & Therapy, 2017, v. 19, p. 1, doi. 10.1186/s13075-017-1240-1
- By:
- Publication type:
- Article
The burden of asthma among South Asian and Chinese populations residing in Ontario.
- Published in:
- Canadian Respiratory Journal, 2014, v. 21, n. 6, p. 346, doi. 10.1155/2014/160476
- By:
- Publication type:
- Article
Persistent proteinuria and dyslipidemia increase the risk of progressive chronic kidney disease in lupus erythematosus.
- Published in:
- Kidney International, 2011, v. 79, n. 8, p. 914, doi. 10.1038/ki.2010.525
- By:
- Publication type:
- Article
Do repeated assessments of performance status improve predictions for risk of death among patients with cancer? A population-based cohort study.
- Published in:
- Palliative Medicine, 2015, v. 29, n. 6, p. 547, doi. 10.1177/0269216314568231
- By:
- Publication type:
- Article
Outcome of carfilzomib/pomalidomide-based regimens after daratumumab-based treatment in relapsed multiple myeloma: A Canadian Myeloma Research Group Database analysis.
- Published in:
- European Journal of Haematology, 2023, v. 111, n. 5, p. 815, doi. 10.1111/ejh.14082
- By:
- Publication type:
- Article
Correction to: Psoriasis in systemic lupus erythematosus: a single-center experience.
- Published in:
- Clinical Rheumatology, 2019, v. 38, n. 1, p. 269, doi. 10.1007/s10067-018-4363-0
- By:
- Publication type:
- Article
Comparison of systemic lupus erythematosus (SLE) patients managed early after diagnosis in specialty versus community care clinics.
- Published in:
- Clinical Rheumatology, 2017, v. 36, n. 8, p. 1773, doi. 10.1007/s10067-017-3713-7
- By:
- Publication type:
- Article
Psoriasis in systemic lupus erythematosus: a single-center experience.
- Published in:
- Clinical Rheumatology, 2017, v. 36, n. 4, p. 879, doi. 10.1007/s10067-017-3566-0
- By:
- Publication type:
- Article
Serum S100A8/A9 and MMP-9 levels are elevated in systemic lupus erythematosus patients with cognitive impairment.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2023.1326751
- By:
- Publication type:
- Article
Assessing the Utility of the Montreal Cognitive Assessment in Screening for Cognitive Impairment in Patients With Systemic Lupus Erythematosus.
- Published in:
- Arthritis Care & Research, 2023, v. 75, n. 3, p. 569, doi. 10.1002/acr.24971
- By:
- Publication type:
- Article
Medium Versus High Initial Prednisone Dose for Remission Induction in Lupus Nephritis: A Propensity Score–Matched Analysis.
- Published in:
- Arthritis Care & Research, 2022, v. 74, n. 9, p. 1451, doi. 10.1002/acr.24592
- By:
- Publication type:
- Article
Cognitive Function Trajectories in Association With the Depressive Symptoms Trajectories in Systemic Lupus Erythematosus Over Time.
- Published in:
- Arthritis Care & Research, 2021, v. 73, n. 10, p. 1436, doi. 10.1002/acr.24349
- By:
- Publication type:
- Article
Identifying a Response for the Systemic Lupus Erythematosus Disease Activity 2000 Glucocorticoid Index.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Validity Evidence for the Use of Automated Neuropsychologic Assessment Metrics As a Screening Tool for Cognitive Impairment in Systemic Lupus Erythematosus.
- Published in:
- Arthritis Care & Research, 2020, v. 72, n. 12, p. 1809, doi. 10.1002/acr.24096
- By:
- Publication type:
- Article
Clinical Remission and Low Disease Activity Outcomes Over 10 Years in Systemic Lupus Erythematosus.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Comparison of the Sensitivity to Change of the 36-Item Short Form Health Survey and the Lupus Quality of Life Measure Using Various Definitions of Minimum Clinically Important Differences in Patients With Active Systemic Lupus Erythematosus.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Defining Low Disease Activity in Systemic Lupus Erythematosus.
- Published in:
- Arthritis Care & Research, 2017, v. 69, n. 7, p. 997, doi. 10.1002/acr.23109
- By:
- Publication type:
- Article
Disease Outcomes in Glucocorticosteroid-Naive Patients With Systemic Lupus Erythematosus.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Defining Low Disease Activity in Systemic Lupus Erythematosus.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Does Renin-Angiotensin System Blockade Protect Lupus Nephritis Patients From Atherosclerotic Cardiovascular Events? A Case-Control Study.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Utility of Urinary Protein-Creatinine Ratio and Protein Content in a 24-Hour Urine Collection in Systemic Lupus Erythematosus: A Systematic Review and Meta-Analysis.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Job Accommodations Availability and Utilization Among People With Lupus: An Examination of Workplace Activity Limitations and Work Context Factors.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Utility of untimed single urine protein/creatinine ratio as a substitute for 24-h proteinuria for assessment of proteinuria in systemic lupus erythematosus.
- Published in:
- Arthritis Research & Therapy, 2015, v. 17, p. 1, doi. 10.1186/s13075-015-0808-x
- By:
- Publication type:
- Article
Isolated Neutropenia in Systemic Lupus Erythematosus.
- Published in:
- Journal of Rheumatology, 2023, v. 50, n. 3, p. 459, doi. 10.3899/jrheum.220373
- By:
- Publication type:
- Article
Effect of Disease Activity on Organ Damage Progression in Systemic Lupus Erythematosus: University of Toronto Lupus Clinic Cohort.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Dr. Tselios, reply.
- Published in:
- 2019
- By:
- Publication type:
- Letter to the Editor
Abnormal Cardiac Biomarkers in Patients with Systemic Lupus Erythematosus and No Prior Heart Disease: A Consequence of Antimalarials?
- Published in:
- Journal of Rheumatology, 2019, v. 46, n. 1, p. 64, doi. 10.3899/jrheum.171436
- By:
- Publication type:
- Article
Abnormal Cardiac Biomarkers in Patients with Systemic Lupus Erythematosus and No Prior Heart Disease: A Consequence of Antimalarials?
- Published in:
- 2018
- By:
- Publication type:
- journal article
Evolution of Risk Factors for Atherosclerotic Cardiovascular Events in Systemic Lupus Erythematosus: A Longterm Prospective Study.
- Published in:
- Journal of Rheumatology, 2017, v. 44, n. 12, p. 1841, doi. 10.3899/jrheum.161121
- By:
- Publication type:
- Article
Evolution of Risk Factors for Atherosclerotic Cardiovascular Events in Systemic Lupus Erythematosus: A Longterm Prospective Study.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Performance of Screening Tests for Cognitive Impairment in Systemic Lupus Erythematosus.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Mycophenolate Mofetil in Refractory Cutaneous Lupus Erythematosus: No Definitive Evidence.
- Published in:
- 2016
- By:
- Publication type:
- Letter
Dr. Tselios, et al reply.
- Published in:
- 2016
- By:
- Publication type:
- Letter
Modified Framingham Risk Factor Score for Systemic Lupus Erythematosus.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Antimalarials as a risk factor for elevated muscle enzymes in systemic lupus erythematosus.
- Published in:
- Lupus, 2016, v. 25, n. 5, p. 532, doi. 10.1177/0961203315617845
- By:
- Publication type:
- Article